Trial Outcomes & Findings for Tear Lipid Layer Thickness With Emollient Eye Drops (NCT NCT03380624)

NCT ID: NCT03380624

Last Updated: 2021-02-03

Results Overview

Change in tear lipid layer thickness

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

21 participants

Primary outcome timeframe

15 minutes

Results posted on

2021-02-03

Participant Flow

2 participants were found to be ineligible after completing the baseline visit.

Participant milestones

Participant milestones
Measure
Refresh Optive Then Refresh Optive MEGA 3
The subjects are randomly assigned to one drop of Refresh Optive or Refresh Optive MEGA followed by measurement of lipid layer thickness at 15 minutes and 1 hour After which there is a washout period before Visit 2 - in which the measurements were repeated with the other eye drop.
Refresh Optive MEGA 3 Then Refresh Optive
The subjects are randomly assigned to one drop of Refresh Optive or Refresh Optive MEGA followed by measurement of lipid layer thickness at 15 minutes and 1 hour After which there is a washout period before Visit 2 - in which the measurements were repeated with the other eye drop.
Overall Study
STARTED
10
9
Overall Study
COMPLETED
10
9
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Refresh Optive and Refresh Optive MEGA
n=19 Participants
The subjects are randomly assigned to Refresh Optive or Refresh Optive MEGA (Omega 3) with measurements of lipid layer thickness following at 15 minutes and 1 hour. After which there is a washout period before proceeding to the second eye drop at visit 2. Refresh Optive: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose Refresh Optimum OMEGA 3: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose and with flaxseed oil and trehalose \*All subjects completed both arms in this crossover study
Age, Customized
Age 30 to 65
19 Participants
n=19 Participants
Sex: Female, Male
Female
13 Participants
n=19 Participants
Sex: Female, Male
Male
6 Participants
n=19 Participants
Lipid layer thickness
40.9 nm
STANDARD_DEVIATION 10.1 • n=19 Participants

PRIMARY outcome

Timeframe: 15 minutes

Change in tear lipid layer thickness

Outcome measures

Outcome measures
Measure
Refresh Optive
n=19 Participants
Participants were first randomized to have 1 drop of Refresh Optive instilled in each eye with measurements of lipid layer thickness following at 15 minutes and 1 hour. After which there is a washout period before proceeding to a second visit in which Refresh Optive MEGA-3 was utilized and the measurements were repeated. Refresh Optive: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose Refresh Optimum OMEGA 3: Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose and with flaxseed oil and trehalose \*All subjects completed both arms in this crossover study
Refresh Optive MEGA-3
n=19 Participants
Participants were first randomized to have 1 drop of Refresh Optive MEGA-3 instilled in each eye with measurements of lipid layer thickness following at 15 minutes and 1 hour. After which there is a washout period before proceeding to a second visit in which Refresh Optive was utilized and the measurements were repeated.
Change in Tear Lipid Layer Thickness
4.8 nm
Standard Deviation 14.9
8.8 nm
Standard Deviation 11.5

Adverse Events

Refresh Optive

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Refresh Optive MEGA

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jennifer Fogt

The Ohio State University College of Optometry

Phone: 614-292-2020

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place